Study: Enzyme could be potential drug target for rare leukemia

09/17/2008 | Reuters

U.S. scientists found that blocking the enzyme glycogen synthase kinase, which can combat certain cancers, by using a drug for bipolar disorder helped prolong the life of mice with mixed-lineage leukemia, a rare form of disease that affects infants. The finding may prove useful in developing "better inhibitors that can be administered long term," one of the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA